Tredje Ap Fonden Incyte Corp Transaction History

Tredje Ap Fonden

$10.8 Billion
Q3 2024

A detailed history of Tredje Ap Fonden transactions in Incyte Corp stock. As of the latest transaction made, Tredje Ap Fonden holds 29,689 shares of INCY stock, worth $2.13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

29,689

Previous 29,689 -0.0%

Holding current value

$2.13 Million

Previous $1.8 Million 9.06%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$51.18 - $63.75 $23,952 - $29,835	-468 Reduced 1.55%	29,689 $1.8 Million
Q4 2023 Feb 12, 2024	SELL	$52.16 - $64.19 $59,358 - $73,048	-1,138 Reduced 3.64%	30,157 $1.89 Million
Q3 2023 Nov 09, 2023	SELL	$57.77 - $65.93 $168,226 - $191,988	-2,912 Reduced 8.51%	31,295 $1.81 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $359,117 - $444,904	-5,892 Reduced 14.69%	34,207 $2.13 Million
Q1 2023 May 10, 2023	BUY	$70.23 - $86.01 $131,891 - $161,526	1,878 Added 4.91%	40,099 $2.9 Million
Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $71,613 - $89,661	1,066 Added 2.87%	38,221 $3.07 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $2.46 Million - $3.08 Million	37,155 New	37,155 $2.48 Million
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $1.08 Million - $1.3 Million	-13,332 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$63.18 - $85.97 $1.05 Million - $1.43 Million	-16,620 Reduced 55.49%	13,332 $2.24 Million
Q4 2019 Feb 10, 2020	BUY	$73.04 - $95.72 $941,485 - $1.23 Million	12,890 Added 75.55%	29,952 $2.62 Million
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $349,681 - $415,469	4,802 Added 39.17%	17,062 $1.27 Million
Q1 2019 May 10, 2019	BUY	$63.56 - $88.17 $59,492 - $82,527	936 Added 8.27%	12,260 $1.05 Million
Q4 2018 Feb 11, 2019	BUY	$58.5 - $69.94 $15,736 - $18,813	269 Added 2.43%	11,324 $720,000
Q2 2018 Aug 09, 2018	SELL	$60.85 - $83.98 $87,076 - $120,175	-1,431 Reduced 11.46%	11,055 $741,000
Q1 2018 May 09, 2018	BUY	$83.06 - $100.98 $85,551 - $104,009	1,030 Added 8.99%	12,486 $1.04 Million
Q4 2017 Feb 12, 2018	SELL	$93.56 - $116.6 $1.11 Million - $1.38 Million	-11,840 Reduced 50.82%	11,456 $1.09 Million
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $2.54 Million - $3.22 Million	23,296	23,296 $2.72 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account